WO1992011052A1 - Anesthesia emergence system using closed-loop pco¿2? - Google Patents

Anesthesia emergence system using closed-loop pco¿2? Download PDF

Info

Publication number
WO1992011052A1
WO1992011052A1 PCT/US1991/009380 US9109380W WO9211052A1 WO 1992011052 A1 WO1992011052 A1 WO 1992011052A1 US 9109380 W US9109380 W US 9109380W WO 9211052 A1 WO9211052 A1 WO 9211052A1
Authority
WO
WIPO (PCT)
Prior art keywords
inspired
value
feedback
patient
breathing circuit
Prior art date
Application number
PCT/US1991/009380
Other languages
French (fr)
Inventor
Daniel Raemer
Original Assignee
Brigham And Women's Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham And Women's Hospital filed Critical Brigham And Women's Hospital
Publication of WO1992011052A1 publication Critical patent/WO1992011052A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/08Bellows; Connecting tubes ; Water traps; Patient circuits
    • A61M16/0816Joints or connectors
    • A61M16/0841Joints or connectors for sampling
    • A61M16/085Gas sampling
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/021Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes operated by electrical means
    • A61M16/022Control means therefor
    • A61M16/024Control means therefor including calculation means, e.g. using a processor
    • A61M16/026Control means therefor including calculation means, e.g. using a processor specially adapted for predicting, e.g. for determining an information representative of a flow limitation during a ventilation cycle by using a root square technique or a regression analysis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0045Means for re-breathing exhaled gases, e.g. for hyperventilation treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0057Pumps therefor
    • A61M16/0075Bellows-type
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0057Pumps therefor
    • A61M16/0081Bag or bellow in a bottle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/22Carbon dioxide-absorbing devices ; Other means for removing carbon dioxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/02Gases
    • A61M2202/0225Carbon oxides, e.g. Carbon dioxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/40Respiratory characteristics
    • A61M2230/43Composition of exhalation
    • A61M2230/432Composition of exhalation partial CO2 pressure (P-CO2)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00Surgery
    • Y10S128/914Rebreathing apparatus for increasing carbon dioxide content in inhaled gas

Definitions

  • the invention relates generally to a C0 2 feedback system and more particularly to a system for rapidly restoring the ventilatory drive of an anesthetized patent.
  • Anesthesia is the loss of sensation in the body induced by the administration of a drug. There are many risks associated with the drug- induced loss of sensation and without proper equipment and skilled operators, complications often occur. Because there are risks associated with anesthesia, it is preferable that an anesthetized patient emerge from anesthesia and that ventilatory drive be restored as soon as possible.
  • the ability of patients to breathe on their own upon emergence from anesthesia is dependent upon three conditions.
  • the blood concentration of anesthetic agent must be low, less than about .2% for isoflurane. This is achieved by turning off the anesthetic agent, washing the agent from the breathing circuit, and ventilating the patient with a normal minute volume for several minutes.
  • Minimum volume is the total volume of gas delivered to or expired by a patient over one minute. Hyperventilation can be used to accelerate the process of removing the anesthetic agent from the body. However, hyperventilation causes C0 2 to be expired from the lung and lowers the partial pressure of C0 2
  • the P,C0 2 must be high enough to adequately stimulate the central ventilatory center in the brain.
  • the ventilatory response to C0 2 is a continuous function, but, a P a C0 2 between 35 mmHg and 44 mmHg is normally required to stimulate ventilatory efforts in the patient recovering from anesthesia.
  • the Jeretin patent states that low arterial C0 2 content resulting from hyperventilation is brought to a standard value by increasing C0 2 content in the inspiration air.
  • the C0 2 in this system comes, however, from the patient's own expired gas, not from an external source. Control of this process is based on a continuous measuring of the partial pressure of C0 2 .
  • the serious problems associated with anesthesiology and in particular restoring the ventilatory drive of a patient are not addressed by the Jeretin patent. Previous attempts to restore the ventilatory drive to an anesthetized patient involves such things as bypassing the C0 2 absorber.
  • This technique while partially effective in raising the C0 2 in the inspired mixture has the problem of reintroducing the anesthesia agent to the patient.
  • the patient rebreathes anesthetic agent as well as the C0 2 .
  • Such a process inhibits resuscitation of the patient.
  • the C0 2 concentration may not be high enough to raise the P a C0 2 to the desired level rapidly and reliably.
  • Yet another object of the invention is to provide a system which is automated to enable effective emergence from anesthesia while minimizing the risk of operator error. It is yet a further object of the invention to optimize the introduction of C0 2 to a patient to minimize risks and complications associated with prolonged anesthesia.
  • the method for restoring ventilatory drive to an anesthetized patient of the present invention includes the step of measuring the end- tidal value of the respiratory partial pressure of carbon dioxide P----C0 2 of r the anesthetized patient.
  • the next step in the method is to estimate the partial pressure of carbon dioxide within the blood stream of the patient
  • P a C0 2 (P a C0 2 ) using the measured end-tidal value of the respiratory partial pressure of carbon dioxide.
  • the estimated P a C0 2 is then compared with a reference value to determine whether C0 2 is to be added to the breathing circuit and the amount to be added. Finally, C0 2 is added directly to the breathing circuit of the patient in the amount determined.
  • a flow meter is used to detect the phases of the respiratory cycle to differentiate between expired end-tidal C0 2 and the increase in C0 2 partial pressure due to the addition of C0 2 into the breathing circuit.
  • the addition of C0 2 into the breathing circuit is inhibited if the average inspired C0 2 concentration exceeds a reference value.
  • Another aspect of the invention is the device used for restoring ventilatory drive to an anesthetized patient.
  • the device of the present invention includes a device for determining the partial pressure of carbon dioxide in the bloodstream of a patient, and a feedback control system which utilizes the partial pressure of carbon dioxide in the bloodstream to control the addition of C0 2 into the inspiration line of the breathing circuit of an anesthetized patient.
  • Figure 1 is a schematic representation of the feedback control system of the present invention.
  • Figure 2 is a block diagram of a digital PID controller used in the feedback control system of the present invention.
  • Figure 3 is a block diagram of flow computation within the feedback control system of the present invention.
  • Figure 4 is a block diagram of a actuator usm g secondary feedback for accuracy.
  • the present invention is a device and method for rapidly restoring ventilatory drive to a patient after anesthesia. While the invention can be embodied in various different manners, the following description of the invention helps to exemplify one preferred prescription for carrying out the practice of the invention.
  • Figure 1, appended hereto is a schematic representation of a prefered embodiment of the invention.
  • a breathing circuit commonly known as the "anesthesia circle system,” identified generally as 10, includes a number of features which are generally known in the art.
  • the breathing circuit includes an inspiration line 12 and an expiration line 14.
  • the inspiration line 12 is the conduit in the breathing circuit by which gases are delivered to a patient.
  • a one-way inspiration valve 13 which assures that the flow of gas through the inspiration line 12 is unidirectional. Gases and vapors (for example anesthesic vapors entrained with ventilation gases) may be dehvered to a patient (not shown) via port 16.
  • the breathing circuit 10 further includes an expiration line 14 for receiving expired gases from the patient. Within the expiration line is a one-way expiration valve 15 for preventing exhaled gases from being reintroduced to a patient.
  • a C0 2 absorber 18 is located downstream of the one-way expiration valve 15. The C0 2 absorber is located in the circuit in order to make rebreathing in the close-circuit possible.
  • a prefered C0 2 absorber for use in breathing circuit 10 is one which has a lack of toxicity with common anesthetic, low air flow impedence, efficiency in removing C0 2 , and ease of handling. Two possible C0 2 absorbers include soda lime
  • C0 2 absorbers are a well known component of a breathing circuit for anesthesia and that any known C0 2 absorber can be used as a substitute for the specific chemical absorbers described above.
  • Expired gases passing through C0 2 absorber 18 are recirculated and entrained with other gases and passed back through the inspiration line 14, to the patient.
  • a ventilator 22 is used in conjuction with the invention to deliver gas to a patient. Any conventional ventilator 22 may be used when practicing the invention.
  • ventilator 22 will include breathing bellows 23 located within a clear plastic receptacle 24. The schematical representation of the ventilator does not show details because ventilators are well known.
  • bellows 23 of ventilator 22 separates a driving gas circuit from a patient gas circuit. The driving gas is located between the bellows 23 and the receptacle 24. During the phase of the cycle when the patient is inspiring gases, the driving gas exerts force on the bellows 23, causing the anesthetic gas within the bellows 23 to be dehvered to a patient.
  • the driving gas is vented to the atmosphere through a relief valve (not shown).
  • anesthetic gas which is in the breathing circuit fills the bellows.
  • Excess gas is vented through a relief valve (not shown) when the bellows 23 are full; vented excess gases may include both fresh gas and expired gas.
  • any anesthesia ventilator may be used to practice the invention including pneumatic and electronic ventilators.
  • An anesthesiologist also has the option of providing ventilation manually from the bag 26.
  • Selector valve 25 is used to select between manual ventilation or ventilation via the ventilator 22. During manual ventilation, most of the expired gas and fresh gas fills the bag 26. The anesthesiologist then squeezes the bag to provide positive pressure for inspiration.
  • An adjustable pressure limiting (APL) valve 31 may be built into the same assembly as the selector valve 25 or may be in a separate assembly. The APL valve 31 limits the maximum pressure in the circuit during manual ventilation. It is especially important to limit the maximum pressure during manual operation as a hard squeeze on bag 26 could subject the patient's lungs to an excessive pressure. It is also important to limit the maximum pressure during expiration because a high flow of fresh gas into the circuit could raise the pressure to an unsafe level.
  • Anesthesia machine 28 which delivers fresh gas to the breathing circuit 10.
  • An anesthesia machine may, for example, properly mix oxygen (0 2 ) with nitrous oxide (N 2 0) for delivery to a patient.
  • a generic anesthesia machine may include a supply of nitrous oxide which passes through a pressure regulator, a fail-safe device and a flow meter. The flow of nitrous oxide through the flow meter is controlled by a valve. Similarly, a supply of oxygen passes through an oxygen pressure regulator, to an oxygen flowmeter. After passing the nitrous oxide and the oxygen through flow meters, one for each gas, the gases are entrained and passed through one of a series of calibrated vaporizers. The resultant gas then exits the anesthesia machine through fresh gas hose 30.
  • the present invention is a control system which introduces C0 2 gas into breathing circuit 10 during emergence from anesthesia. Instead of providing a bypass of the C0 2 absorber, as has been previously attempted, C0 2 gas is dehvered directly into the inspiration line 12 of breathing circuit 10.
  • the present invention is a negative feedback control system and method which utilizes the partial pressure of the end tidal C0 2 expired by a patient (P----C0 2 ) to control the quantity of C0 2 which is dehvered to inspiration line 12 of breathing circuit 10.
  • C0 2 gas is passed through a C0 2 hose 36 into a mixing zone 32 for delivery into breathing circuit 10 via delivery hose 34.
  • Carbon dioxide is dehvered directly into the inspiration line 12 and thus increases the partial pressure of C0 2 in the blood to a level adequate to stimulate the central ventilatory center of the brain.
  • a pair of time-controlled valves 37 can be used to determine the amount of time that C0 2 is added to the inspired line 12.
  • the proportion of time of CO z addition can also be controlled through duty cycle control.
  • duty cycle control the ratio of on-time to off-time can be controlled by rapidly turning valve 37 on and off.
  • the valves 37 are controlled by controller 52. Valves 37 and the controller 52 are described in greater detail later in the specification.
  • the ability of a patient to breathe on their own after anesthesia is a function of several variables.
  • One of these variables is the concentration of anesthesia agent in the blood of the patient.
  • the blood concentration of the anesthesia agent must be low in order for the patient to breathe on his/her own. This is acheived by turning off the anesthesia agent, washing the agent from breathing circuit 10 and ventilating the patient.
  • Hyperventilation helps accelerate the process of removing anesthesia agent from the patient. Because hyperventilation causes carbon dioxide to be expired from the lungs, lowering the partial pressure of carbon dioxide in the blood, the invention introduces carbon dioxide directly into the breathing circuit to counteract the lowering of carbon dioxide in the blood due to hyperventilation.
  • the contoller system is designated generally by reference number 42 and is deliniated in Figure 1 by a broken line.
  • the controller system 42 also refered to hereinafter as the feedback control system, includes a number of subcomponents or subsystems which are used to practice the invention.
  • the invention measures the partial pressure of carbon dioxide being expired by a patient. Using this measurement of the end tidal partial pressure of carbon dioxide P----C0 2 , the partial pressure of carbon dioxide in the patient's blood (the arterial blood carbon dioxide tension) P a C0 2 can be estimated. The end tidal pressure of carbon dioxide is used to estimate P a C0 2 . The value of P a C0 2 is then compared with a reference value.
  • the reference value generally the desired PC0 2 value
  • P a C0 2 the estimated value of P a C0 2
  • carbon dioxide is introduced into the inspiration line of the breathing circuit at a rate which is a function of the measured difference between the reference amount and the end tidal pressure of carbon dioxide.
  • Expired gas is tapped from the breathing circuit 10 through a sample port 38.
  • a capnometer 44 such as is commercially available, is used to measure the respiratory partial pressure of carbon dioxide (or carbon dioxide concentration). The capnometer may measure the carbon dioxide concentration by measuring the amount of infrared radiation absorbed by carbon dioxide molecules. A particular review band of wavelength measured for this purpose is around 4.25 microns.
  • the principle of operation of the capnometer may be Raman spectroscopy, mass spectroscopy, acoustic spectroscopy, or gas chromatography.
  • a capnometer using a curvette mounted directry in line with the breathing circuit may also be used. Such a capnometer does not require a sample port 38 but is mounted directly on the curvette. The curvette is ordinarily mounted where sample port 38 would come into the circuit.
  • Raman spectroscopy as its principle of operation, a beam of light passes through the gas medium. A certain portion of the light passing through the sample is absorbed, a certain portion is transmitted (passes through the sample), and a certain portion is scattered.
  • the capnometer sub-system 46 measures P----C0 2 using a commercial instrument and reports the raw signal to a computer.
  • An algorithm processes the signal to measure P-p.r_-.CO2 m tne P resence °f inspired CO ⁇ . This is necessary because the algorithms in commercial capnometers cannot measure P ET C ⁇ 2 when the inspired PCO ⁇ is higher than a few mm Hg or when pulses of C0 2 appear during inspiration.
  • the output from capnometer subsystem 46 goes directly to the feedback controller 48 to be compared to a reference. The measured is displayed to the user.
  • a feedback controller 48 compares the measured and reference point
  • the feedback compensation is designed to produce a stable control response, zero-steady state error, and limited overshoot.
  • the feedback is principally adaptive as a function of minute ventilation, the system may also be adaptive as a function of tidal volume, respiratory rate or the type of circuit in general. Also, it may be necessary to use a crude measure of fresh gas flow to optimize the system response.
  • the feedback is designed to be tolerant of missing or artifactual data.
  • the user interface 50 allows the physician or operator to enter data into the controller 48 via a PC computer. Principally, a set-point for Pg- CO- may be chosen.
  • the display provides data to the physician or operator informing him/her of system status, Pp- j -CO ⁇ set-point, measured
  • the C0 2ADD controller 52 interfaces the feedback controller signal to the flow of C0 2 into the fresh gas.
  • the desired CO ⁇ A control signal is converted to drive the pair of time-controlled valves 37 which are pneumatically connected in series.
  • the time-controlled valves 37 are preferably solenoid valves although one of ordinary skill will appreciate that other types of valves may also be used.
  • the valves 37 are switched open and closed approximately once per second. The proportion of time the valves 37 are open relative to the time the valves are closed is in proportion to the control signal. When the valves 37 are open, the flow of C0 2 gas is allowed to pass into the fresh gas line.
  • Two valves 37 are used instead of one as a safety measure. If one valve malfunctions in the open position, the other valve will prevent the unabated flow of C0 2 into the fresh gas flow.
  • the opening and closing of each of the two valves 37 are controlled by an independent digital electronic circuit.
  • the logic of the digital circuits is designed so that the removal or open-circuit failure of any of the components results in a control signal to its respective valve 37 which renders it closed.
  • the C0 2 is provided to the valves 37 from a precision two-stage pressure regulator and series linear fluid resistor. These components limit the total flow of C0 2 to approximately 500 ml/min as a safety measure.
  • a pressure relief valve between the pressure regulator and the fluid resistor limits the pressure to a safe level should the regulator fail.
  • a flow transducer in series with the gas flow control components may be used to command the solenoid valves to close if a component failure causes excessive gas flow.
  • a Fresh Gas Flow Monitor (FGFM) 54 is a series component of the system and measures total fresh gas flow to the breathing circuit.
  • FGFM is a self-heated thermistor flow meter with an accuracy of about
  • the FGFM is a safety feature which assures that pure or concentrated C0 2 is not added to the circuit accidentally. It is important for the added C0 2 to mix with fresh gas.
  • the signal from this transducer is used to disable the CO ⁇ ⁇ TY ⁇ system when the fresh gas flow is below a certain value (e.g., 1 L/min).
  • the FGFM signal may be used to adapt the feedback parameters of the controller to refine the system dynamic response.
  • flow meters which would be suitable as an FGFM.
  • the principle of operation of a suitable FGFM could be any among thermal transport, momentum (vane), vortex precession, or Poiseuille's law, among others.
  • the present invention can be optimized and varied without departing from the above described general principle of providing a feedback control system which introduces C0 2 into the inspired mixture of a patient as a function of the end tidal value of the respiratory PC0 2 .
  • the invention can be refined by introducing C0 2 into the feedback control system which introduces C0 2 into the inspired mixture of a patient as a function of the end tidal value of the respiratory PC0 2 .
  • the invention can be refined by introducing C0 2 into the inspired mixture only during the inspiration cycle of the patient.
  • a flow meter can be used for detecting the phases of the respiratory cycle.
  • C0 2 gas can then be added to the inspired mixture in concert with the desired phase (such as the inspiration phase).
  • the C0 2 waveform which is measured by capnometer 44 can be processed to differentiate
  • the present invention measures the P ET C0 2 and computes a feedback compensation value which is related to the difference between the desired
  • the flow rate of the C0 2 gas which is added to the breathing mixture of a patient is controlled by an electronic signal.
  • the output which controls the flow rate of the added C0 2 gas is a function of the sum of three terms:
  • O error difference between the desired P ET C0 2 and the measured P ET C0 2
  • dE(t)/dt is the time derivative of E(t).
  • the output may be adjusted by a constant of proportionality as circumstance may dictate.
  • the patients minute ventilation, tidal volume, or respiratory rate may be used to modify one or more of the terms in the above circuit equation.
  • the patients minute ventilation, tidal volume or respiratory rate may be measured using any well-known technique. For example, these measurements may be made based if the on thermal dissipation, a pressure difference across a resistive element (pneumotachograph), the rotation rate of a vane, or the oscillation frequency of a fluid vortex.
  • K 2 and K 3 are coefficients of the proportional integral and derivative terms, respectively.
  • T is the sample time interval
  • k is an integer number of sample intervals
  • Z is the Z-transform operator. Note that K j , K 2 and K 3 serve the same purpose as C ls C and C-, in the analog implementation discussed previously; however, the values of K j , K- and
  • K 3 may be different from C j , C, and C 3 .
  • the transfer function of the digital PID controller is as follows:
  • a block diagram of this process is shown in Figure 3.
  • the values of the coefficients as shown in Figure 3 are dependent on the characteristics of the design of the system which is being controlled.
  • the increment (n), error (E), flow (F) and the output are functions of the volume and flow characteristics of the breathing circuit, the patient's lung and C0 2 transfer characteristics, and the settings of the ventilator and anesthesia machine.
  • design goals such as tolerable overshoot, time to achieve control and accuracy of control are used to determine the value of coefficients K ls K 2 and K 3 .
  • An additional feedback loop, as shown in Figure 4, may also be used to increase accuracy.
  • a measurement of the inspired or added PC0 2 can be compared to a reference value to adjust the C0 2 added into the breathing circuit.
  • the inspired C0 2 may be also measured by the capnometer subsystem 46 while the added C0 2 may be measured in the mixing zone 32.
  • controllers which can also be used in the closed-loop PC0 2 control.
  • good control in such a system can often be accomplished with just a PI controller (a controller with only proportional and integral terms), or a controller based upon bilinear transform, deadbeat, state feedback, optimal, linear digital regulator, digital state observer, minimal variance or the like.
  • the flow of C0 2 gas into the inspiration line 12 of circuit 10 may be controlled with a solenoid value which responds to the processor output.
  • a solenoid value which responds to the processor output.
  • other controllable gas flow regulators can be used to control the flow of C0 2 .
  • a mass flow controller, an electro-mechanically controlled needle valve, an electro-mechanically controlled pressure regulator and a fixed pneumatic resistance device can also be used to control the flow of C0 2 .
  • a safety subsystem is designated 56 in Figure 1.
  • a flow measuring device such as one which measures thermal dissipation, pressure difference across a resistive element, the rate of rotation of a vane or the oscillation frequency of a fluid vortex, may be used to measure the total fresh gas flow into the breathing circuit. The measurement of fresh gas flow within breathing circuit 10 is then compared with a fresh gas flow reference value of about
  • the concentration of oxygen 0 2 within breathing circuit 10 can be measured and flow of C0 2 into the flow circuit is inhibited if the concentration of 0 2 falls below a reference value. If the 0 2 concentration falls below 21%, it is particularly critical to cease C0 2 addition. For additional safety, however, C0 2 addition should be stopped when the 0 2 concentration falls below 30%.
  • Another safety system may be used in conjunction with the feedback control system which measures the average inspired carbon dioxide concentration within breathing circuit 10. If the average inspired C0 2 concentration exceeds a value of about 7%, no more C0 2 is introduced into the system.
  • C0 2 can be introduced into the system once the parameters within the breathing circuit dictate that it is safe to add C0 2 . For example, once the concentration of C0 2 falls below the reference value, C0 2 can again be introduced into the breathing circuit.
  • Yet another safety system is the use of a device which detects the absence of breathing for a particular duration of time. If there is an absence of breathing, an alarm signals the anesthesiologist.
  • a series of safety features are implemented in the hardware and software to prevent hypoxic inspired mixtures and inadvertent operation of the system. These include:
  • the submitted computer program shown on the following two pages, demonstrates the digital PID controller for the C0 2 ADD system of the instant invention.

Abstract

A system is disclosed for rapidly restoring ventilatory drive to an anesthetized patient after surgery. The end-expired carbon dioxide partial pressure is used as feedback to determine the amount of CO2 to be added to the inspired breathing mixture of the patient's breathing circuit (10). The CO2 added (52) to the patient's breathing circuit (10) increases CO2 within the blood stream to a level sufficient to stimulate the central ventilatory center in the brain, thereby rapidly restoring ventilatory drive to the patient.

Description

TITLE OF THE INVENTION
"ANESTHESIA EMERGENCE SYSTEM USING CLOSED-LOOP PC02"■
Field of the Invention
The invention relates generally to a C02 feedback system and more particularly to a system for rapidly restoring the ventilatory drive of an anesthetized patent.
Background of the Invention
Anesthesia is the loss of sensation in the body induced by the administration of a drug. There are many risks associated with the drug- induced loss of sensation and without proper equipment and skilled operators, complications often occur. Because there are risks associated with anesthesia, it is preferable that an anesthetized patient emerge from anesthesia and that ventilatory drive be restored as soon as possible.
The ability of patients to breathe on their own upon emergence from anesthesia is dependent upon three conditions. First, the blood concentration of anesthetic agent must be low, less than about .2% for isoflurane. This is achieved by turning off the anesthetic agent, washing the agent from the breathing circuit, and ventilating the patient with a normal minute volume for several minutes. "Minute volume" is the total volume of gas delivered to or expired by a patient over one minute. Hyperventilation can be used to accelerate the process of removing the anesthetic agent from the body. However, hyperventilation causes C02 to be expired from the lung and lowers the partial pressure of C02
(PC02) in the blood, PaC02 (arterial blood carbon dioxide tension). Second, if a neuromuscular function blocking drug had been used, it must be adequately reversed for sufficient ventilatory muscle strength to return. This is accomplished pharmacologically.
Third, the P,C02 must be high enough to adequately stimulate the central ventilatory center in the brain. The ventilatory response to C02 is a continuous function, but, a PaC02 between 35 mmHg and 44 mmHg is normally required to stimulate ventilatory efforts in the patient recovering from anesthesia.
Unfortunately, increasing PaC02 by hypoventilation can lead to complications such as hypoxia. Also, the awakening process is actually prolonged by the failure to remove anesthetic agent from the patient's body. Thus, the clinician is faced with a dilemma; the clinician must both remove the anesthetic agent by hyperventilation and increase the arterial blood carbon dioxide tension, PgCOj, by hypoventilation. Some anesthesia machines have been manufactured with a valve that allows bypassing the C02 absorber in a circle system breathing circuit. Bypassing the C02 absorber permits the patient to rebreath expired C02 gases thus the PC02 rises in the inspired gas. However, this does not substantially hasten awakening because if the system is mostly closed, anesthetic agent is also recirculated to the patient Therefore, even though the patient is able to rebreath expired C02 and thereby increase the arterial blood carbon dioxide tension, the patient also rebreaths expired anesthesia agent. If the system was mostly open, little rise in PC02 can be achieved. Also, such a design requires the clinician to remember to shut off the bypass, before the next procedure. Failure to turn off the bypass, however, was not an infrequent occurrence and occasionally contributed to complications.
In order to increase the PaC02 of a patient, it is helpful to measure PaC02. While measurements of C02 from the expired breathing gas have long been used to estimate the PaC02, this information has not been used to rapidly restore ventilatory drive to a patient after anesthesia. The gas at the end of each tidal ventilation is assumed to be in equilibrium with the arterial blood. Hence, the end-tidal C02 partial pressure, Pj---C02, is often used to estimate PaC02. For example, U.S. Patent No. 4,423,739 to Passaro et al. discloses an apparatus for determining the partial pressure of C02 in the arterial blood of a patient by measuring carbon dioxide concentration at the end-tidal of a patient's exhaled breath.
The practice of using the partial pressure of C02 in the arterial blood of a patient to control respiration has been in use for several years. For example, U.S. Patent No. 4,112,938 to Jeretin discloses a device for controlling patient respiration in accordance with the partial pressure of
C02 in the arterial blood or tissue measured in the alveolar expiration air. The Jeretin patent states that low arterial C02 content resulting from hyperventilation is brought to a standard value by increasing C02 content in the inspiration air. The C02 in this system comes, however, from the patient's own expired gas, not from an external source. Control of this process is based on a continuous measuring of the partial pressure of C02. The serious problems associated with anesthesiology and in particular restoring the ventilatory drive of a patient are not addressed by the Jeretin patent. Previous attempts to restore the ventilatory drive to an anesthetized patient involves such things as bypassing the C02 absorber. This technique, while partially effective in raising the C02 in the inspired mixture has the problem of reintroducing the anesthesia agent to the patient. For example, in the Jeretin device, the patient rebreathes anesthetic agent as well as the C02. Such a process inhibits resuscitation of the patient. It is one object of the present invention to solve this problem. Furthermore, as rebreathing limits the inspired PC02 to the patient's mean expired PC02, the C02 concentration may not be high enough to raise the PaC02 to the desired level rapidly and reliably. It is the object of the present invention to also solve this problem. Yet another object of the invention is to provide a system which is automated to enable effective emergence from anesthesia while minimizing the risk of operator error. It is yet a further object of the invention to optimize the introduction of C02 to a patient to minimize risks and complications associated with prolonged anesthesia.
Summary of the Invention
To achieve the foregoing and other objects, and in accordance with the purposes of the present invention as embodied and broadly described herein, the method for restoring ventilatory drive to an anesthetized patient of the present invention includes the step of measuring the end- tidal value of the respiratory partial pressure of carbon dioxide P----C02 of r the anesthetized patient. The next step in the method is to estimate the partial pressure of carbon dioxide within the blood stream of the patient
(PaC02) using the measured end-tidal value of the respiratory partial pressure of carbon dioxide. The estimated PaC02 is then compared with a reference value to determine whether C02 is to be added to the breathing circuit and the amount to be added. Finally, C02 is added directly to the breathing circuit of the patient in the amount determined.
In one aspect of the invention a flow meter is used to detect the phases of the respiratory cycle to differentiate between expired end-tidal C02 and the increase in C02 partial pressure due to the addition of C02 into the breathing circuit.
In yet another aspect of the invention, the addition of C02 into the breathing circuit is inhibited if the average inspired C02 concentration exceeds a reference value. Another aspect of the invention is the device used for restoring ventilatory drive to an anesthetized patient. The device of the present invention includes a device for determining the partial pressure of carbon dioxide in the bloodstream of a patient, and a feedback control system which utilizes the partial pressure of carbon dioxide in the bloodstream to control the addition of C02 into the inspiration line of the breathing circuit of an anesthetized patient.
Brief Description of the Drawings
The accompanying drawing, which is incorporated in and forms a part of the specification, illustrates the present invention, and together with the written description, serves to explain the principles of the invention. In the drawing:
Figure 1 is a schematic representation of the feedback control system of the present invention. Figure 2 is a block diagram of a digital PID controller used in the feedback control system of the present invention.
Figure 3 is a block diagram of flow computation within the feedback control system of the present invention.
Figure 4 is a block diagram of a
Figure imgf000007_0001
actuator usmg secondary feedback for accuracy.
Description of the Preferred Embodiment
The present invention is a device and method for rapidly restoring ventilatory drive to a patient after anesthesia. While the invention can be embodied in various different manners, the following description of the invention helps to exemplify one preferred prescription for carrying out the practice of the invention. Figure 1, appended hereto, is a schematic representation of a prefered embodiment of the invention.
Refering to Figure 1, a breathing circuit commonly known as the "anesthesia circle system," identified generally as 10, includes a number of features which are generally known in the art. The breathing circuit includes an inspiration line 12 and an expiration line 14. The inspiration line 12 is the conduit in the breathing circuit by which gases are delivered to a patient. Within the inspiration line 14 is a one-way inspiration valve 13 which assures that the flow of gas through the inspiration line 12 is unidirectional. Gases and vapors (for example anesthesic vapors entrained with ventilation gases) may be dehvered to a patient (not shown) via port 16.
The breathing circuit 10 further includes an expiration line 14 for receiving expired gases from the patient. Within the expiration line is a one-way expiration valve 15 for preventing exhaled gases from being reintroduced to a patient. A C02 absorber 18 is located downstream of the one-way expiration valve 15. The C02 absorber is located in the circuit in order to make rebreathing in the close-circuit possible. A prefered C02 absorber for use in breathing circuit 10 is one which has a lack of toxicity with common anesthetic, low air flow impedence, efficiency in removing C02, and ease of handling. Two possible C02 absorbers include soda lime
(94% calcium hydroxide, 5% sodium hydroxide, and 1% potassium hydroxide as an activator; with small amounts of silica added) and baratyme (80% calcium hydroxide, and 20% barium hydroxide). The process of absorption using soda lime or barah ne is a chemical process and not a physical one. C02 absorbers are a well known component of a breathing circuit for anesthesia and that any known C02 absorber can be used as a substitute for the specific chemical absorbers described above.
Expired gases passing through C02 absorber 18 are recirculated and entrained with other gases and passed back through the inspiration line 14, to the patient.
A ventilator 22 is used in conjuction with the invention to deliver gas to a patient. Any conventional ventilator 22 may be used when practicing the invention. Typically, ventilator 22 will include breathing bellows 23 located within a clear plastic receptacle 24. The schematical representation of the ventilator does not show details because ventilators are well known. Generally, bellows 23 of ventilator 22 separates a driving gas circuit from a patient gas circuit. The driving gas is located between the bellows 23 and the receptacle 24. During the phase of the cycle when the patient is inspiring gases, the driving gas exerts force on the bellows 23, causing the anesthetic gas within the bellows 23 to be dehvered to a patient. During the expiration phase, the driving gas is vented to the atmosphere through a relief valve (not shown). Thereafter, anesthetic gas which is in the breathing circuit fills the bellows. Excess gas is vented through a relief valve (not shown) when the bellows 23 are full; vented excess gases may include both fresh gas and expired gas. As stated above, any anesthesia ventilator may be used to practice the invention including pneumatic and electronic ventilators.
An anesthesiologist also has the option of providing ventilation manually from the bag 26. Selector valve 25 is used to select between manual ventilation or ventilation via the ventilator 22. During manual ventilation, most of the expired gas and fresh gas fills the bag 26. The anesthesiologist then squeezes the bag to provide positive pressure for inspiration. An adjustable pressure limiting (APL) valve 31 may be built into the same assembly as the selector valve 25 or may be in a separate assembly. The APL valve 31 limits the maximum pressure in the circuit during manual ventilation. It is especially important to limit the maximum pressure during manual operation as a hard squeeze on bag 26 could subject the patient's lungs to an excessive pressure. It is also important to limit the maximum pressure during expiration because a high flow of fresh gas into the circuit could raise the pressure to an unsafe level.
Also used in conjunction with the present invention is a standard anesthesia machine 28 which delivers fresh gas to the breathing circuit 10. An anesthesia machine may, for example, properly mix oxygen (02) with nitrous oxide (N20) for delivery to a patient. A generic anesthesia machine may include a supply of nitrous oxide which passes through a pressure regulator, a fail-safe device and a flow meter. The flow of nitrous oxide through the flow meter is controlled by a valve. Similarly, a supply of oxygen passes through an oxygen pressure regulator, to an oxygen flowmeter. After passing the nitrous oxide and the oxygen through flow meters, one for each gas, the gases are entrained and passed through one of a series of calibrated vaporizers. The resultant gas then exits the anesthesia machine through fresh gas hose 30.
The present invention is a control system which introduces C02 gas into breathing circuit 10 during emergence from anesthesia. Instead of providing a bypass of the C02 absorber, as has been previously attempted, C02 gas is dehvered directly into the inspiration line 12 of breathing circuit 10. The present invention is a negative feedback control system and method which utilizes the partial pressure of the end tidal C02 expired by a patient (P----C02) to control the quantity of C02 which is dehvered to inspiration line 12 of breathing circuit 10. In the embodiment of the invention shown in Figure 1, C02 gas is passed through a C02 hose 36 into a mixing zone 32 for delivery into breathing circuit 10 via delivery hose 34. Carbon dioxide is dehvered directly into the inspiration line 12 and thus increases the partial pressure of C02 in the blood to a level adequate to stimulate the central ventilatory center of the brain. A pair of time-controlled valves 37 can be used to determine the amount of time that C02 is added to the inspired line 12.
Furthermore, the proportion of time of COz addition can also be controlled through duty cycle control. During duty cycle control, the ratio of on-time to off-time can be controlled by rapidly turning valve 37 on and off. The valves 37 are controlled by controller 52. Valves 37 and the
Figure imgf000010_0001
controller 52 are described in greater detail later in the specification.
One of ordinary skill in the art will appreciate that other available techniques may be used for measuring the partial pressure of C02 in a patient's bloodstream. For example, there are commerically available devices that may also be used in the invention which analyze blood directly. These devices, called continuous blood gas analyzers, typically use electrochemical or electro-optical sensors to perform this function.
As stated above, the ability of a patient to breathe on their own after anesthesia is a function of several variables. One of these variables is the concentration of anesthesia agent in the blood of the patient. The blood concentration of the anesthesia agent must be low in order for the patient to breathe on his/her own. This is acheived by turning off the anesthesia agent, washing the agent from breathing circuit 10 and ventilating the patient. Hyperventilation helps accelerate the process of removing anesthesia agent from the patient. Because hyperventilation causes carbon dioxide to be expired from the lungs, lowering the partial pressure of carbon dioxide in the blood, the invention introduces carbon dioxide directly into the breathing circuit to counteract the lowering of carbon dioxide in the blood due to hyperventilation. The
Figure imgf000011_0001
contoller system is designated generally by reference number 42 and is deliniated in Figure 1 by a broken line. The controller system 42, also refered to hereinafter as the feedback control system, includes a number of subcomponents or subsystems which are used to practice the invention. Broadly, the invention measures the partial pressure of carbon dioxide being expired by a patient. Using this measurement of the end tidal partial pressure of carbon dioxide P----C02, the partial pressure of carbon dioxide in the patient's blood (the arterial blood carbon dioxide tension) PaC02 can be estimated. The end tidal pressure of carbon dioxide is used to estimate PaC02. The value of PaC02 is then compared with a reference value. If the reference value, generally the desired PC02 value, exceeds the estimated value of PaC02, then carbon dioxide is introduced into the inspiration line of the breathing circuit at a rate which is a function of the measured difference between the reference amount and the end tidal pressure of carbon dioxide. The subcomponents of the present invention are described in detail below. Expired gas is tapped from the breathing circuit 10 through a sample port 38. A capnometer 44, such as is commercially available, is used to measure the respiratory partial pressure of carbon dioxide (or carbon dioxide concentration). The capnometer may measure the carbon dioxide concentration by measuring the amount of infrared radiation absorbed by carbon dioxide molecules. A particular review band of wavelength measured for this purpose is around 4.25 microns. Alternatively, the principle of operation of the capnometer may be Raman spectroscopy, mass spectroscopy, acoustic spectroscopy, or gas chromatography. Furthermore, a capnometer using a curvette mounted directry in line with the breathing circuit may also be used. Such a capnometer does not require a sample port 38 but is mounted directly on the curvette. The curvette is ordinarily mounted where sample port 38 would come into the circuit. In the operation of a capnometer 44 using Raman spectroscopy as its principle of operation, a beam of light passes through the gas medium. A certain portion of the light passing through the sample is absorbed, a certain portion is transmitted (passes through the sample), and a certain portion is scattered. Some of the light which is scattered undergoes a shift in frequency or wavelength as the light is scattered; this is a characteristic of the gas molecules. The shift occurs because of a loss in energy as a result of the collision with the gas medium. The intensity of Raman scattered light at specific frequencies gives a measure of the concentration of gas constituents. Mass spectroscopy separates components on the basis of mass and charge rather than physical characteristics. By contrast gas chromatography first separates the components of a gas mixture and then measures their individual concentrations.
The capnometer sub-system 46 measures P----C02 using a commercial instrument and reports the raw signal to a computer. An algorithm processes the signal to measure P-p.r_-.CO2 m tne Presence °f inspired CO^. This is necessary because the algorithms in commercial capnometers cannot measure PETCθ2 when the inspired PCO^ is higher than a few mm Hg or when pulses of C02 appear during inspiration. The output from capnometer subsystem 46 goes directly to the feedback controller 48 to be compared to a reference. The measured
Figure imgf000013_0001
is displayed to the user.
A feedback controller 48 compares the measured and reference point
Figure imgf000013_0002
The feedback compensation is designed to produce a stable control response, zero-steady state error, and limited overshoot. Although the feedback is principally adaptive as a function of minute ventilation, the system may also be adaptive as a function of tidal volume, respiratory rate or the type of circuit in general. Also, it may be necessary to use a crude measure of fresh gas flow to optimize the system response. The feedback is designed to be tolerant of missing or artifactual data. The user interface 50 allows the physician or operator to enter data into the controller 48 via a PC computer. Principally, a set-point for Pg- CO- may be chosen. The display provides data to the physician or operator informing him/her of system status, Pp-j-CO^ set-point, measured
Figure imgf000013_0003
The C02ADD controller 52 interfaces the feedback controller signal to the flow of C02 into the fresh gas. The desired CO~ A control signal is converted to drive the pair of time-controlled valves 37 which are pneumatically connected in series. The time-controlled valves 37 are preferably solenoid valves although one of ordinary skill will appreciate that other types of valves may also be used. The valves 37 are switched open and closed approximately once per second. The proportion of time the valves 37 are open relative to the time the valves are closed is in proportion to the control signal. When the valves 37 are open, the flow of C02 gas is allowed to pass into the fresh gas line. Two valves 37 are used instead of one as a safety measure. If one valve malfunctions in the open position, the other valve will prevent the unabated flow of C02 into the fresh gas flow. The opening and closing of each of the two valves 37 are controlled by an independent digital electronic circuit. As a safety measure, the logic of the digital circuits is designed so that the removal or open-circuit failure of any of the components results in a control signal to its respective valve 37 which renders it closed. The C02 is provided to the valves 37 from a precision two-stage pressure regulator and series linear fluid resistor. These components limit the total flow of C02 to approximately 500 ml/min as a safety measure. In addition, a pressure relief valve between the pressure regulator and the fluid resistor limits the pressure to a safe level should the regulator fail. Also, a flow transducer in series with the gas flow control components may be used to command the solenoid valves to close if a component failure causes excessive gas flow.
A Fresh Gas Flow Monitor (FGFM) 54 is a series component of the system and measures total fresh gas flow to the breathing circuit. The
FGFM is a self-heated thermistor flow meter with an accuracy of about
+20%. The FGFM is a safety feature which assures that pure or concentrated C02 is not added to the circuit accidentally. It is important for the added C02 to mix with fresh gas. The signal from this transducer is used to disable the CO^ Λ TYΠ system when the fresh gas flow is below a certain value (e.g., 1 L/min). Also, the FGFM signal may be used to adapt the feedback parameters of the controller to refine the system dynamic response. There are commercially available flow meters which would be suitable as an FGFM. The principle of operation of a suitable FGFM could be any among thermal transport, momentum (vane), vortex precession, or Poiseuille's law, among others.
The present invention can be optimized and varied without departing from the above described general principle of providing a feedback control system which introduces C02 into the inspired mixture of a patient as a function of the end tidal value of the respiratory PC02.
For example the invention can be refined by introducing C02 into the feedback control system which introduces C02 into the inspired mixture of a patient as a function of the end tidal value of the respiratory PC02. For example the invention can be refined by introducing C02 into the inspired mixture only during the inspiration cycle of the patient. To 5 accomphsh this end, a flow meter can be used for detecting the phases of the respiratory cycle. C02 gas can then be added to the inspired mixture in concert with the desired phase (such as the inspiration phase).
In one preferred embodiment of the invention, the C02 waveform which is measured by capnometer 44 can be processed to differentiate
10 between the expired peak value which is attainable to the expiration of
C02 gases by a patient and inspired peak value which is produced as a result of additional C02 being added to the breathing circuit. Both inspired and expired gases are being tapped via sample port 38. Therefore, it is important to distinguish the source of the C02. By
15 processing the C02 waveform, an accurate estimate of PaC02 can be established.
Utilizing a PID (Proportional-Integral-Derivative) controller, the present invention measures the PETC02 and computes a feedback compensation value which is related to the difference between the desired
20 and measured PETC02. The flow rate of the C02 gas which is added to the breathing mixture of a patient is controlled by an electronic signal. The output which controls the flow rate of the added C02 gas is a function of the sum of three terms:
C, £(+) Y(t) = C. . E(f) + C- E(i)dt + C- 3 dt
where Y(t) is the output signal, Cj, C2 and C3 are constants, E(t) is the
O error (difference between the desired PETC02 and the measured PETC02) and dE(t)/dt is the time derivative of E(t). The output may be adjusted by a constant of proportionality as circumstance may dictate.
It is also possible to use the patients minute ventilation, tidal volume, or respiratory rate to modify one or more of the terms in the above circuit equation. The patients minute ventilation, tidal volume or respiratory rate may be measured using any well-known technique. For example, these measurements may be made based if the on thermal dissipation, a pressure difference across a resistive element (pneumotachograph), the rotation rate of a vane, or the oscillation frequency of a fluid vortex.
Although the above is an analog implementation of a feedback controller, it is also possible to use a sampled-data equivalent of a feedback controller. This is commonly used with microcomputers. The block diagram of the digital PID controller is shown in Figure 2. The microcomputer samples the input variable (error between a desired and a measured C02) periodically (every T seconds). Computer software is used to mathematically implement the feedback algorithm described above. A listing of the computer code is appended to this specification.
While the output of the digital controller is presented every T seconds, a circuit element called a zero-order-hold takes the periodically produced output, holds it steady and implements the output action of adding C02.
In the block diagram of the digital PID controller in Figure 2, K,
K2 and K3 are coefficients of the proportional integral and derivative terms, respectively. T is the sample time interval, k is an integer number of sample intervals, and Z is the Z-transform operator. Note that Kj, K2 and K3 serve the same purpose as Cls C and C-, in the analog implementation discussed previously; however, the values of Kj, K- and
K3 may be different from Cj, C, and C3. The transfer function of the digital PID controller is as follows:
Figure imgf000017_0001
A block diagram of this process is shown in Figure 3. The values of the coefficients as shown in Figure 3 are dependent on the characteristics of the design of the system which is being controlled. The increment (n), error (E), flow (F) and the output are functions of the volume and flow characteristics of the breathing circuit, the patient's lung and C02 transfer characteristics, and the settings of the ventilator and anesthesia machine. Furthermore, design goals such as tolerable overshoot, time to achieve control and accuracy of control are used to determine the value of coefficients Kls K2 and K3. An additional feedback loop, as shown in Figure 4, may also be used to increase accuracy. A measurement of the inspired or added PC02 can be compared to a reference value to adjust the C02 added into the breathing circuit. The inspired C02 may be also measured by the capnometer subsystem 46 while the added C02 may be measured in the mixing zone 32.
One of ordinary skill in the art will appreciate that there are a variety of controllers which can also be used in the closed-loop PC02 control. For example, good control in such a system can often be accomplished with just a PI controller (a controller with only proportional and integral terms), or a controller based upon bilinear transform, deadbeat, state feedback, optimal, linear digital regulator, digital state observer, minimal variance or the like.
The flow of C02 gas into the inspiration line 12 of circuit 10 may be controlled with a solenoid value which responds to the processor output. Alternatively, other controllable gas flow regulators can be used to control the flow of C02. For example, a mass flow controller, an electro-mechanically controlled needle valve, an electro-mechanically controlled pressure regulator and a fixed pneumatic resistance device can also be used to control the flow of C02.
A number of safety features may be incorporated in and made a part of the present invention. Generally, a safety subsystem is designated 56 in Figure 1. For example, a flow measuring device, such as one which measures thermal dissipation, pressure difference across a resistive element, the rate of rotation of a vane or the oscillation frequency of a fluid vortex, may be used to measure the total fresh gas flow into the breathing circuit. The measurement of fresh gas flow within breathing circuit 10 is then compared with a fresh gas flow reference value of about
1 L/min. If the reference value exceeds the measured value of the fresh gas flow, the flow of C02 gas into breathing circuit 10 is inhibited.
Similarly, the concentration of oxygen 02 within breathing circuit 10 can be measured and flow of C02 into the flow circuit is inhibited if the concentration of 02 falls below a reference value. If the 02 concentration falls below 21%, it is particularly critical to cease C02 addition. For additional safety, however, C02 addition should be stopped when the 02 concentration falls below 30%.
Another safety system may be used in conjunction with the feedback control system which measures the average inspired carbon dioxide concentration within breathing circuit 10. If the average inspired C02 concentration exceeds a value of about 7%, no more C02 is introduced into the system. As with the other above described safety systems, C02 can be introduced into the system once the parameters within the breathing circuit dictate that it is safe to add C02. For example, once the concentration of C02 falls below the reference value, C02 can again be introduced into the breathing circuit.
Yet another safety system is the use of a device which detects the absence of breathing for a particular duration of time. If there is an absence of breathing, an alarm signals the anesthesiologist. A series of safety features are implemented in the hardware and software to prevent hypoxic inspired mixtures and inadvertent operation of the system. These include:
1. System reset based on absence of C02 waveforms 2. System reset based on low FGF
3. ^2ADD disable based on pressure, flow, or electronic abnormality
4. System reset based on low FI02
5. Pneumatic and electronic "fail-off design 6. Independent watch-dog microcomputer design strategy
The submitted computer program, shown on the following two pages, demonstrates the digital PID controller for the C02ADD system of the instant invention.
One of ordinary skill will appreciate that there are a large number of control mechanisms and breathing circuits which may be used in this invention. For example, A Practice of Anaesthesia, W.B. Saunders Co.: Philadelphia, 1978, pp. 110-118, herein incorporated by reference, discusses a number of breathing circuits which can be used in this invention. While the apparatus and method herein disclosed and described constitute preferred forms of the invention, it is to be understood that modifications and alterations within the spirit of the invention are anticipated, and that such mechanical arrangements and adaptations as fall within the scope of the claims are intended to be included herein.

Claims

I CLAIM:
1. A method for restoring ventilatory drive to an anesthesized patient, the method comprising:
(a) measuring the end-tidal value of the respiratory PC02 of the patient;
(b) comparing said measurement of the end-tidal value of the respiratory PC02 with a reference value as feedback to determine the amount of C02 to be added to a patient's breathing circuit; and
(c) adding said amount of C02 to the inspired mixture of the patient's breathing circuit.
2. The method of claim 1 wherein a device is used to detect the phases of a respiratory cycle.
3. The method of claim 2 wherein the C02 gas is added only during the inspired phase of the respiratory cycle.
4. The method of claim 3 wherein phases are detected by a flow meter.
5. The method of claim 1 further comprising the step of differentiating between the expired end-tidal C02 value and a inspired peak C02 value produced by the addition of C02 into the breathing mix- ture such that the effect of the inspired peak C02 value on the C02 addition is minimized.
6. The method of claim 1 wherein said feedback is determined by a term which is a function of difference between a desired and a measured PETC02.
7. The method of claim 1 wherein said feedback is determined by a term which is proportional to the time integral of the difference between a desired and a measured PETC02.
8. The method of claim 1 wherein said feedback is determined by a term which is proportional to the derivative with respect to time of the difference between a desired and a measured PETC02.
9. The method of claim 1 further comprising the step of controlling the time or the proportion of time a valve is left open to introduce the correct flow of C02 into the breathing mixture.
10. The method of claim 1 further comprising the step of measuring the total fresh gas flow into the subject's breathing circuit and inhibiting the addition of C02 gas into the circuit when the fresh gas flow is less than a particular value.
11. The method of claim 1 further comprising the step of measuring 02 concentration within the breathing circuit and inhibiting C02 addition into the circuit when the 02 concentration is less than a particular value.
12. The method of claim 1 further comprising the step of measuring the average inspired C02 concentration within the breathing circuit and inhibiting C02 addition into the circuit when the average inspired C02 concentration exceeds a particular value. 13. The method of claim 1 further comprising the step of detecting an absence of breathing for a particular duration of time and triggering an alarm upon said absence of breathing.
14. The method of claim 5 wherein the inspired peak value is greater than 2 mm Hg.
15. A device for restoring ventilatory drive to an anethesized subject comprising:
(a) means for determining the partial pressure of C02 in the bloodstream of a subject; (b) feedback means utilizing said determination of the partial pressure of C02 in the blood stream of a subject, and
(c) means for adding C02 into breathing circuit as deter¬ mined by the feedback means.
16. The device of claim 15 wherein said means for determining the partial pressure of C02 in the bloodstream measures the end-tidal value of the respiratory PC02.
17. The device of claim 16 wherein said feedback means computes the difference between a desired value of PETC02 and the measured value of PEχC02.
18. The device of claim 17 wherein said feedback means computes feedback compensation as a function on said difference.
19. The device of claim 15 wherein said means for adding C02 gas to the inspired mixture introduces C02 into the inspired mixture only during certain phases of the respiratory cycle. 20. The device of claim 15 wherein said feedback means differentiates between the expired peak value of C02 from the inspired peak value of C02 which may be produced by the addition of C02 to the breathing mixture.
21. The method of claim 1 further comprising estimating the partial pressure of C02 within the patient's bloodstream by measuring the end-tidal value of the respiratory PC0 .
22. The method of claim 1 wherein said feedback computes feedback compensation as a function of the difference between a desired value of PETC02 and the measured value of PETC02.
23. The method of claim 1 further comprising the step of comparing said added amount of C02 with a reference value to determine the amount of C02 to be added to the patient's breathing circuit.
24. The method of claim 1 further comprising the step of measuring the inspired PC02 and comparing the inspired amount of C02 with a reference value to determine the amount of C02 to be added to the patient's breathing circuit.
25. The device of claim 15 further comprising means for measuring the inspired PC02 of a subject and second feedback means for comparing said measured inspired PC02 with a reference value for determining the amount of C02 to be added into the breathing circuit.
26. The device of claim 15 further comprising means for comparing said added C02 with a reference value for determining the amount of C02 to be added into the breathing circuit. 92 11 52
AMENDED CLAIMS
[received by the International Bureau on 10 June 1992 (10.06.92) ; original claims 15-26 replaced by amended claims 15-21 ; other claims unchanged (2 pages)]
13. The method of claim 1 further comprising the step of detecting an absence of breathing for a particular duration of time and triggering an alarm upon said absence of breathing.
14. The method of claim 5 wherein the inspired peak value is greater than 2 mm Hg.
15. The method of claim 1 further comprising estimating the partial pressure of C02 within the patient's bloodstream by measuring the end-tidal value of the respiratory PC02.
16. The method of claim 1 wherein said feedback computes feedback compensation as a function of the difference between a desired value of PETC02 and the measured value of PETC02.
17. The method of claim 1 further comprising the step of comparing said added amount of C02 with a reference value to determine the amount of C02 to be added to the patient's breathing circuit.
18. The method of claim 1 further comprising the step of measuring the inspired PC02 and comparing the inspired amount of C02 with a reference value to determine the amount of C02 to be added to the patient's breathing circuit.
19. A device for restoring ventilatory drive to an anethesized subject comprising:
(a) means for determining the partial pressure of C02 in the bloodstream of a subject;
(b) feedback means utilizing said determination of the partial pressure of COo in the blood stream of a subject, said feedback means differentiating between the expired peak value of C02 from the inspired peak value of C02 which may be produced by the addition of C02 to the breathing mixture; and
(c) means for adding C02 into breathing circuit as deter¬ mined by the feedback means.
20. A device for restoring ventilatory drive to an anethesized subject comprising:
(a) means for determining the partial pressure of C02 in the bloodstream of a subject;
(b) first feedback means utilizing said determination of the partial pressure of C02 in the blood stream of a subject;
(c) means for adding C02 into breathing circuit as deter¬ mined by the feedback means;
(d) means for measuring the inspired PC02 of a subject; and (e) second feedback means for comparing said measured inspired PC02 with a reference value for determining the amount of C02 to be added into the breathing circuit.
21. A device for restoring ventilatory drive to an anethesized subject comprising: (a) means for determining the partial pressure of C02 in the bloodstream of a subject;
(b) feedback means utilizing said determination of the partial pressure of C02 in the blood stream of a subject;
(c) means for adding C02 into breathing circuit as deter- mined by the feedback means; and
(d) means for comparing said added C02 with a reference value for determining the amount of C02 to be added into the breathing circuit.
PCT/US1991/009380 1990-12-21 1991-12-13 Anesthesia emergence system using closed-loop pco¿2? WO1992011052A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US632,002 1990-12-21
US07/632,002 US5320093A (en) 1990-12-21 1990-12-21 Rapid anesthesia emergence system using closed-loop PCO2 control

Publications (1)

Publication Number Publication Date
WO1992011052A1 true WO1992011052A1 (en) 1992-07-09

Family

ID=24533676

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1991/009380 WO1992011052A1 (en) 1990-12-21 1991-12-13 Anesthesia emergence system using closed-loop pco¿2?

Country Status (3)

Country Link
US (1) US5320093A (en)
AU (1) AU9167591A (en)
WO (1) WO1992011052A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0621051A2 (en) * 1993-04-17 1994-10-26 MESSER GRIESHEIM AUSTRIA Ges.m.b.H. Apparatus for the controlled dosage of NO to a patient's air supply
EP0659445A1 (en) * 1993-11-22 1995-06-28 Ohmeda Inc. Nitric oxide delivery system
WO1997020591A1 (en) * 1995-12-06 1997-06-12 Messer Griesheim Gmbh Analytical configuration for monitoring xenon-containing anaesthetic gas
EP0832662A3 (en) * 1996-09-26 1998-09-02 Ohmeda Inc. Anaesthesia systems
US6131572A (en) * 1998-05-20 2000-10-17 Instrumentarium Oy Medical dosing device having dosing chamber with a pressure sensor
US6197323B1 (en) 1997-03-10 2001-03-06 Michael Georgieff Medicinal preparation containing a lipophilic inert gas
US7861717B1 (en) 1997-01-17 2011-01-04 Ino Therapeutics Gmbh Controlled gas-supply system
EP2696927A1 (en) * 2011-04-13 2014-02-19 Michael Klein Gas delivery method and apparatus

Families Citing this family (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004865A1 (en) * 1990-09-19 1992-04-02 The University Of Melbourne Arterial co2 monitor and closed loop controller
USRE35552E (en) * 1991-04-15 1997-07-08 Leiras Oy Device intended for measuring a dose of powered medicament for inhalation
FI945649A0 (en) * 1994-11-30 1994-11-30 Instrumentarium Oy Foerfarande och anordning Foer indentifiering av en koppling vid ventilation av en patient
SE506208C2 (en) * 1995-07-05 1997-11-24 Aerocrine Systems Kb Device for collecting gas from the upper respiratory tract and delivering this gas to the inhalation air in a respirator
US5778874A (en) * 1996-10-02 1998-07-14 Thomas Jefferson University Anesthesia machine output monitor
US5806513A (en) * 1996-10-11 1998-09-15 Ohmeda Inc. Method and apparatus for controlling a medical anesthesia delivery system
US5778872A (en) * 1996-11-18 1998-07-14 Medlis, Inc. Artificial ventilation system and methods of controlling carbon dioxide rebreathing
US6439231B1 (en) 1996-11-18 2002-08-27 Medlis Corp. Artificial ventilation systems and components thereof, and methods for providing, assembling and utilizing same
US6003511A (en) 1996-11-18 1999-12-21 Medlis Corp. Respiratory circuit terminal for a unilimb respiratory device
US6306098B1 (en) * 1996-12-19 2001-10-23 Novametrix Medical Systems Inc. Apparatus and method for non-invasively measuring cardiac output
CA2283430C (en) 1997-03-19 2006-05-23 Joseph A. Fisher Elimination of vapour anaesthetics from patients after surgical procedures
US5975078A (en) * 1997-07-22 1999-11-02 Pauley; Randall O. Respiratory monitoring apparatus
US6216690B1 (en) 1997-10-15 2001-04-17 Datex-Ohmeda, Inc. Method and apparatus for rapid control of set inspired gas concentration in anesthesia delivery systems
US6099481A (en) * 1997-11-03 2000-08-08 Ntc Technology, Inc. Respiratory profile parameter determination method and apparatus
US6192884B1 (en) * 1998-05-22 2001-02-27 Duke University Method and apparatus for supplemental oxygen delivery
SE9803684D0 (en) * 1998-10-27 1998-10-27 Siemens Elema Ab Anesthesia apparatus
FI110065B (en) * 1998-12-08 2002-11-29 Instrumentarium Oyj Device in a feedback control system
SE522908C2 (en) * 1999-05-10 2004-03-16 Aneo Ab Arrangements for granting a living being an anesthetic condition
US6634355B2 (en) * 1999-06-11 2003-10-21 Colas Marie-Jose Single breath induction anesthesia apparatus
ES2243282T3 (en) 1999-06-30 2005-12-01 University Of Florida Research Foundation, Inc. FAN MONITORING SYSTEM.
US20070000494A1 (en) * 1999-06-30 2007-01-04 Banner Michael J Ventilator monitor system and method of using same
AU1703401A (en) * 1999-11-20 2001-06-04 Michael Hermanussen Device for inhaling medicaments using supported pressure respiration
CA2304292C (en) 2000-03-31 2009-01-13 Joseph Fisher An improved rebreathing circuit to set and stabalize end tidal and arterial pco2 despite varying levels of minute ventilation
CA2346517A1 (en) * 2001-05-04 2002-11-04 Joseph Fisher Improved method of maintaining constant arterial pco2 during increased minute ventilation and measurement of anatomic and alveolar dead space
US6675798B1 (en) * 2001-01-18 2004-01-13 Automed - Automatic Dosage Systems, Ltd. Automatically regulating oxygen flow to a patient
CN1313172C (en) 2001-07-19 2007-05-02 雷斯姆德公司 Method and equipment for pressure support ventilation of patients
US7261105B2 (en) * 2001-09-24 2007-08-28 F-Concepts Llc Breathing circuits having unconventional respiratory conduits and systems and methods for optimizing utilization of fresh gases
MXPA04002687A (en) 2001-09-24 2004-06-18 Atsuo F Fukunaga Breathing circuits having unconventional respiratory conduits and systems and methods for optimising utilisation of fresh gases.
US7717109B2 (en) * 2001-09-24 2010-05-18 F-Concepts Llc Breathing systems with post-inspiratory valve fresh gas flow input, components for implementing same, and methods of use
CA2379353C (en) * 2002-03-28 2012-07-31 Joseph Fisher A new method for continuous measurement of flux of gases in the lungs during breathing
GB0211894D0 (en) * 2002-05-23 2002-07-03 Dingley John Gas supply system
DE10230165A1 (en) * 2002-07-04 2004-01-15 Ino Therapeutics Gmbh Method and device for the administration of carbon monoxide
US6863068B2 (en) * 2002-07-25 2005-03-08 Draeger Medical, Inc. Ventilation sound detection system
DE10238683A1 (en) * 2002-08-19 2004-03-11 Rist, Max, Dr. Device for influencing gas flows
SE0203518D0 (en) * 2002-11-28 2002-11-28 Siemens Elema Ab Hose intended for use in anesthesia system
US6951216B2 (en) * 2002-12-19 2005-10-04 Instrumentarium Corp. Apparatus and method for use in non-invasively determining conditions in the circulatory system of a subject
US7886740B2 (en) * 2003-01-28 2011-02-15 Beth Israel Deaconess Medical Center, Inc. Gas systems and methods for enabling respiratory stability
EP1603447A1 (en) * 2003-02-18 2005-12-14 Fisher, Joseph A simple approach to precisely calculate o2 consumption, and anesthetic absorption during low flow anesthesia
US7353825B2 (en) * 2003-05-01 2008-04-08 Axon Medical, Inc. Apparatus and techniques for reducing the effects of general anesthetics
US7621272B2 (en) * 2003-05-01 2009-11-24 Anecare Laboratories, Inc. Apparatus and techniques for reducing the effects of general anesthetics
US9180266B1 (en) * 2003-07-17 2015-11-10 Zoll Medical Corporation Automatic patient ventilator system and method
US20050092322A1 (en) * 2003-11-05 2005-05-05 Collins William L.Jr. Cannula assembly and medical system employing a known carbon dioxide gas concentration
US7997268B1 (en) * 2003-12-17 2011-08-16 Intellivet Anesthesia Equipment, Llc Veterinary anesthesia monitor system
US7178521B2 (en) * 2004-01-09 2007-02-20 King Systems Corporation Adjustable length breathing circuit
US20050188990A1 (en) * 2004-02-12 2005-09-01 Fukunaga Atsuo F. Multifunctional integrated filter and breathing conduit
KR20050097692A (en) * 2004-04-02 2005-10-10 삼성전자주식회사 Method of fabricating 0ptical fiber preform and drawing optical fiber
DE102004039711B3 (en) * 2004-08-17 2006-05-11 Dräger Medical AG & Co. KG Method for automatic recording of pressure-volume curves in artificial respiration and apparatus for carrying out the method
WO2007012170A1 (en) * 2005-07-28 2007-02-01 Marat Slessarev A new method and apparatus to attain and maintain target end tidal gas concentrations
EP1912694A4 (en) * 2005-07-28 2011-11-09 Marat Slessarev A method and apparatus to attain and maintain target end tidal gas concentrations
US10071218B2 (en) 2006-01-24 2018-09-11 Zoll Medical Corporation Reperfusion protection in resuscitation
US20070169779A1 (en) * 2006-01-24 2007-07-26 Freeman Gary A Reperfusion protection in resuscitation
US7810497B2 (en) * 2006-03-20 2010-10-12 Ric Investments, Llc Ventilatory control system
US7900626B2 (en) * 2006-04-17 2011-03-08 Daly Robert W Method and system for controlling breathing
US20070283958A1 (en) * 2006-05-23 2007-12-13 Ray Naghavi Positive airway pressure device
US20100212666A1 (en) * 2006-06-21 2010-08-26 Universitat Bern System for Controlling Administration of Anaesthesia
US20080066752A1 (en) * 2006-09-20 2008-03-20 Nellcor Puritan Bennett Inc. Method and system for circulatory delay compensation in closed-loop control of a medical device
US20080202522A1 (en) * 2007-02-23 2008-08-28 General Electric Company Setting mandatory mechanical ventilation parameters based on patient physiology
EP1961438A1 (en) * 2007-02-23 2008-08-27 The General Electric Company Inhalation anaesthesia delivery system and method
US20080230062A1 (en) * 2007-03-23 2008-09-25 General Electric Company Setting expiratory time in mandatory mechanical ventilation based on a deviation from a stable condition of exhaled gas volumes
US20080236581A1 (en) * 2007-03-29 2008-10-02 Borje Rantala Method in a patient ventilating system
US20080295839A1 (en) * 2007-06-01 2008-12-04 Habashi Nader M Ventilator Apparatus and System of Ventilation
JP5628669B2 (en) * 2007-06-01 2014-11-19 インテンシブ ケア オン−ライン ネットワーク, インコーポレイテッド Artificial respiratory apparatus and system for ventilation
US20080302365A1 (en) * 2007-06-08 2008-12-11 Cohen Eric D Respiratory Mask
WO2009046215A2 (en) * 2007-10-02 2009-04-09 Lab International Srl Safety and abuse deterrent improved device
WO2009117163A1 (en) * 2008-03-21 2009-09-24 The Periodic Breathing Foundation Llc Nasal interface device
EP2257328A2 (en) 2008-03-27 2010-12-08 Nellcor Puritan Bennett LLC Breathing assistance systems with lung recruitment maneuvers
CN102056539B (en) 2008-06-06 2015-10-07 柯惠有限合伙公司 For making great efforts with patient the system and method that carries out pro rata taking a breath
US20090320836A1 (en) * 2008-06-30 2009-12-31 Baker Jr Clark R Method For Regulating Treatment Based On A Medical Device Under Closed-Loop Physiologic Control
DE102009034642A1 (en) * 2009-07-24 2011-02-03 Philipps-Universität Marburg Respiratory measuring device and method for its operation
US10842502B2 (en) 2009-09-11 2020-11-24 Tbi Innovations, Llc Devices and systems to mitigate traumatic brain and other injuries caused by concussive or blast forces
US8985120B2 (en) * 2009-09-11 2015-03-24 Tbi Innovations, Llc Method to reduce SLOSH energy absorption and its damaging effects through the reduction of inelastic collisions in an organism
US9173660B2 (en) 2009-09-11 2015-11-03 Tbi Innovations, Llc Methods and devices to reduce the likelihood of injury from concussive or blast forces
US10004515B2 (en) 2009-09-11 2018-06-26 Tbi Innovations, Llc Methods and devices to reduce damaging effects of concussive or blast forces on a subject
US9168045B2 (en) 2009-09-11 2015-10-27 Tbi Innovations, Llc Device to reduce SLOSH energy absorption and its damaging effects through the reduction of the flow of one or more outflow vessels of the cranium
US11696766B2 (en) 2009-09-11 2023-07-11 Tbi Innovations, Llc Methods and devices to reduce damaging effects of concussive or blast forces on a subject
EP2431065B1 (en) * 2010-09-15 2020-04-22 General Electric Company Arrangement for ventilating lungs
US10219787B2 (en) * 2010-09-29 2019-03-05 The Board Of Trustees Of The Leland Stanford Junior University Respiratory mode (“R-Mode”)—acquisition and display of cardiovascular images to show respiratory effects
US8783250B2 (en) 2011-02-27 2014-07-22 Covidien Lp Methods and systems for transitory ventilation support
US8714154B2 (en) 2011-03-30 2014-05-06 Covidien Lp Systems and methods for automatic adjustment of ventilator settings
DE202011102764U1 (en) * 2011-07-02 2011-12-05 Dräger Medical GmbH ventilation system
WO2013082703A1 (en) * 2011-12-05 2013-06-13 Michael Klein An apparatus to attain and maintain target end tidal partial pressure of a gas
US10362967B2 (en) 2012-07-09 2019-07-30 Covidien Lp Systems and methods for missed breath detection and indication
US8900169B2 (en) 2013-03-15 2014-12-02 Tbi Innovations, Llc Methods and devices to reduce the likelihood of injury from concussive or blast forces
US9808591B2 (en) 2014-08-15 2017-11-07 Covidien Lp Methods and systems for breath delivery synchronization
US20200016347A1 (en) * 2014-09-10 2020-01-16 Pomozine Gyarmathy Agnes Device for adjustment and/or conditioning of the co2 content of the inhaled air
HUP1400421A2 (en) * 2014-09-10 2016-03-29 Gyarmathy Agnes Dr Pomozine Instrument for adjusting and/or controlling co2 content of inhaled air
US9950129B2 (en) 2014-10-27 2018-04-24 Covidien Lp Ventilation triggering using change-point detection
GB2533799B (en) * 2014-12-30 2017-11-22 Gen Electric Method and system for controlling patient recovery
WO2017087556A1 (en) 2015-11-16 2017-05-26 Q30 Sports Science, Llc Traumatic brain injury protection devices
RU2659136C2 (en) * 2016-04-28 2018-06-28 Федеральное государственное бюджетное образовательное учреждение высшего образования "Тульский государственный университет" (ТулГУ) Anesthesia control system for inhalation anesthesia
US10080521B2 (en) 2016-08-01 2018-09-25 Timothy Joshua Parrish Sleep apnea bi-level positive airway pressure machine with advanced diagnostics and self-cleaning capabilities
CA3099804A1 (en) 2018-05-14 2019-11-21 Covidien Lp Systems and methods for respiratory effort detection utilizing signal distortion
US11752287B2 (en) 2018-10-03 2023-09-12 Covidien Lp Systems and methods for automatic cycling or cycling detection
CN109718444A (en) * 2018-12-29 2019-05-07 北京谊安医疗系统股份有限公司 Control method, control system and the Breathing Suppotion machine of recovery from anesthesia process
US11298498B2 (en) * 2019-05-09 2022-04-12 GE Precision Healthcare LLC Breathing system for anesthesia machine
CN114870179B (en) * 2022-05-25 2023-04-18 广州蓝仕威克医疗科技有限公司 Anesthesia respirator device capable of dynamically monitoring and regulating partial pressure of carbon dioxide
CN115006674B (en) * 2022-05-31 2023-09-05 广州蓝仕威克医疗科技有限公司 Respirator mixed with carbon dioxide and method for solving respiratory failure
CN116688300B (en) * 2023-07-03 2024-02-06 广州蓝仕威克医疗科技有限公司 CO (carbon monoxide) connected with universal breathing machine 2 Other gas compensation devices and systems

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4112938A (en) * 1975-02-25 1978-09-12 Dragerwerk Aktiengesellschaft Device for controlling the respiration in respirators

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2817350A (en) * 1955-06-01 1957-12-24 Bradner Hugh Device for control of oxygen partial pressure
US3593735A (en) * 1968-09-04 1971-07-20 Dick Evans Inc Method and apparatus for maintaining a preselected partial pressure
US3805590A (en) * 1973-03-09 1974-04-23 Us Navy Oxygen partial pressure sensor
US3972327A (en) * 1973-03-22 1976-08-03 Hoffmann-La Roche Inc. Respirator
US3895630A (en) * 1973-06-04 1975-07-22 Del Mar Eng Lab Respiratory gas analyzer including a carbon dioxide and respiratory quotient computer
US3910261A (en) * 1974-06-11 1975-10-07 Bourns Inc End-tidal gas analysis apparatus for respirators
US4121581A (en) * 1976-11-01 1978-10-24 Sandoz, Inc. Patient ventilator monitor
DE2746924C2 (en) * 1977-10-19 1982-09-16 Drägerwerk AG, 2400 Lübeck Ventilator
US4269194A (en) * 1978-02-13 1981-05-26 Rayburn Robert L Carbon dioxide measurement from expired gases in a partial rebreathing anesthesia circuit
US4233842A (en) * 1978-10-20 1980-11-18 University Of Utah Apparatus for measurement of expiration fluids
IT1130983B (en) * 1979-03-21 1986-06-18 Lama Lab Mec Appliquees PROCEDURES AND DEVICES FOR REGULATING THE PARTIAL OXYGEN PRESSURE OF THE GASEOUS MIXTURE OF THE RESPIRATORY CIRCUIT OF A HAMMER
DE2926747C2 (en) * 1979-07-03 1982-05-19 Drägerwerk AG, 2400 Lübeck Ventilation system with a ventilator controlled by patient values
US4440177A (en) * 1980-07-03 1984-04-03 Medical Graphics Corporation Respiratory analyzer system
US4423739A (en) * 1981-08-24 1984-01-03 Andros Analyzers Incorporated End tidal carbon dioxide gas analyzer
FR2517961A1 (en) * 1981-12-11 1983-06-17 Synthelabo Biomedical METHOD AND DEVICE FOR CONTROLLING ARTIFICIAL RESPIRATION
EP0100649B1 (en) * 1982-07-30 1989-01-18 Ronald Dunbar Rae Fluid flow regulator
US4648396A (en) * 1985-05-03 1987-03-10 Brigham And Women's Hospital Respiration detector
US4637385A (en) * 1986-01-13 1987-01-20 Tibor Rusz Pulmonary ventilator controller
US4838257A (en) * 1987-07-17 1989-06-13 Hatch Guy M Ventilator

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4112938A (en) * 1975-02-25 1978-09-12 Dragerwerk Aktiengesellschaft Device for controlling the respiration in respirators

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0621051A2 (en) * 1993-04-17 1994-10-26 MESSER GRIESHEIM AUSTRIA Ges.m.b.H. Apparatus for the controlled dosage of NO to a patient's air supply
EP0621051A3 (en) * 1993-04-17 1994-12-28 Messer Griesheim Gmbh Apparatus for the controlled dosage of NO to a patient's air supply.
EP0659445A1 (en) * 1993-11-22 1995-06-28 Ohmeda Inc. Nitric oxide delivery system
US5558083A (en) * 1993-11-22 1996-09-24 Ohmeda Inc. Nitric oxide delivery system
WO1997020591A1 (en) * 1995-12-06 1997-06-12 Messer Griesheim Gmbh Analytical configuration for monitoring xenon-containing anaesthetic gas
EP0832662A3 (en) * 1996-09-26 1998-09-02 Ohmeda Inc. Anaesthesia systems
US7861717B1 (en) 1997-01-17 2011-01-04 Ino Therapeutics Gmbh Controlled gas-supply system
US6511453B2 (en) 1997-03-10 2003-01-28 Michael Georgieff Device for controlled anaesthesia, analgesia and/or sedation
US6328708B1 (en) 1997-03-10 2001-12-11 Michael Georgieff Device for controlled anaesthesia, analgesia and /or sedation
US6197323B1 (en) 1997-03-10 2001-03-06 Michael Georgieff Medicinal preparation containing a lipophilic inert gas
US6131572A (en) * 1998-05-20 2000-10-17 Instrumentarium Oy Medical dosing device having dosing chamber with a pressure sensor
EP2696927A1 (en) * 2011-04-13 2014-02-19 Michael Klein Gas delivery method and apparatus
EP2696927A4 (en) * 2011-04-13 2015-01-07 Michael Klein Gas delivery method and apparatus
EP3981459A1 (en) * 2011-04-13 2022-04-13 Thornhill Scientific Inc. Gas delivery apparatus
US11464934B2 (en) 2011-04-13 2022-10-11 Thornhill Scientific Inc. Gas delivery method and apparatus

Also Published As

Publication number Publication date
AU9167591A (en) 1992-07-22
US5320093A (en) 1994-06-14

Similar Documents

Publication Publication Date Title
US5320093A (en) Rapid anesthesia emergence system using closed-loop PCO2 control
US7802571B2 (en) Method and apparatus for controlling a ventilator
US4127121A (en) Oxygen and anesthesia delivery and monitoring device
EP0894506B1 (en) On-line detection and correction in anesthesia delivery system
EP1152690B1 (en) Automatic lung parameter estimator
CA2092703C (en) Arterial co2 monitor and closed loop controller
US7900626B2 (en) Method and system for controlling breathing
US6581595B1 (en) Positive airway pressure device with indirect calorimetry system
US20020104537A1 (en) Tracheal pressure ventilation respiratory system
US5673688A (en) Anesthesia system with CO2 monitor to suppress CO2 breakthrough
JPH06105912A (en) Apparatus and method for controlling adaptation for feeding amount of oxygen part to patient
HUE029106T2 (en) System of administering a pharmaceutical gas to a patient
EP1590029A1 (en) Gas systems and methods for enabling respiratory stability
US7070569B2 (en) Non-invasive determination of conditions in the circulatory system of a subject
EP4289459A1 (en) Breathing apparatus with carbon dioxide compensation function
Coles et al. Computer control of respiration and anaesthesia
Ritchie et al. Closed-loop control of an anesthesia delivery system: development and animal testing
Verkaaik et al. High flow closed circuit anaesthesia
Haberthür et al. Effects of mechanical unloading/loading on respiratory loop gain and periodic breathing in man
Tehrani et al. Closed-loop control of artificial respiration
EP2490741B1 (en) Apparatus for respirating of patients
Gregorini Effect of low fresh gas flow rates on inspired gas composition in a circle absorber system

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA